158 related articles for article (PubMed ID: 28121023)
1. LncRNA CASC2 Interacts With miR-181a to Modulate Glioma Growth and Resistance to TMZ Through PTEN Pathway.
Liao Y; Shen L; Zhao H; Liu Q; Fu J; Guo Y; Peng R; Cheng L
J Cell Biochem; 2017 Jul; 118(7):1889-1899. PubMed ID: 28121023
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms for hypoxia
Zhao H; Meng L; Liao X; Liu Y; Mo X; Gong M; Liao Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 47(7):829-838. PubMed ID: 36039578
[TBL] [Abstract][Full Text] [Related]
3. The Role of
Skiriute D; Stakaitis R; Steponaitis G; Tamasauskas A; Vaitkiene P
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33120918
[TBL] [Abstract][Full Text] [Related]
4. Long Non-coding RNA CASC2 Enhances the Antitumor Activity of Cisplatin Through Suppressing the Akt Pathway by Inhibition of miR-181a in Esophageal Squamous Cell Carcinoma Cells.
Zhu D; Yu Y; Qi Y; Wu K; Liu D; Yang Y; Zhang C; Zhao S
Front Oncol; 2019; 9():350. PubMed ID: 31134151
[No Abstract] [Full Text] [Related]
5. Long non-coding RNA EGOT is associated with
Wang M; Wei Z; Wang S; Feng W; Shang L; Sun X
Aging (Albany NY); 2023 Nov; 15(22):13542-13557. PubMed ID: 38006396
[TBL] [Abstract][Full Text] [Related]
6. Depletion of Kruppel-like factor 15 sensitized gliomas to temozolomide cytotoxicity through
Qu X; Liu X; Zhang Y; Shi Z; Wang X
Biochem Biophys Rep; 2021 Sep; 27():101058. PubMed ID: 34222684
[TBL] [Abstract][Full Text] [Related]
7. Clinical Significance of Serum lncRNA Cancer Susceptibility Candidate 2 (CASC2) for Chronic Renal Failure in Patients with Type 2 Diabetes.
Wang L; Su N; Zhang Y; Wang G
Med Sci Monit; 2018 Sep; 24():6079-6084. PubMed ID: 30171178
[TBL] [Abstract][Full Text] [Related]
8. Suppression of miR-181a attenuates H2O2-induced death of mesenchymal stem cells by maintaining hexokinase II expression.
Lee S; Yun I; Ham O; Lee SY; Lee CY; Park JH; Lee J; Seo HH; Choi E; Hwang KC
Biol Res; 2015 Aug; 48(1):45. PubMed ID: 26283227
[TBL] [Abstract][Full Text] [Related]
9. UBE2C enhances temozolomide resistance by regulating the expression of p53 to induce aerobic glycolysis in glioma.
Zhou K; Wang D; Du X; Feng X; Zhu X; Wang C
Acta Biochim Biophys Sin (Shanghai); 2024 Apr; ():. PubMed ID: 38634120
[TBL] [Abstract][Full Text] [Related]
10. NRP1 Induces Enhanced Stemness and Chemoresistance in Glioma Cells via YAP.
Jin L; Jin A; Wang L; Qi X; Jin Y; Zhang C; Niu M
Biol Pharm Bull; 2024; 47(1):166-174. PubMed ID: 38220212
[TBL] [Abstract][Full Text] [Related]
11.
Shi Y; Wu M; Liu Y; Hu L; Wu H; Xie L; Liu Z; Wu A; Chen L; Xu C
Front Oncol; 2021; 11():769592. PubMed ID: 34976814
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA CASC2 induces apoptosis and autophagy in human colon cancer cells via modulation of TRIM16 expression.
Ju B; Liu Z; Nai C; Zhu X
Am J Transl Res; 2020; 12(6):2695-2702. PubMed ID: 32655801
[TBL] [Abstract][Full Text] [Related]
13. KDM5B predicts temozolomide-resistant subclones in glioblastoma.
Ullrich V; Ertmer S; Baginska A; Dorsch M; Gull HH; Cima I; Berger P; Dobersalske C; Langer S; Meyer L; Dujardin P; Kebir S; Glas M; Blau T; Keyvani K; Rauschenbach L; Sure U; Roesch A; Grüner BM; Scheffler B
iScience; 2024 Jan; 27(1):108596. PubMed ID: 38174322
[TBL] [Abstract][Full Text] [Related]
14. Targeting MYH9 represses USP14-mediated NAP1L1 deubiquitination and cell proliferation in glioma.
Chen Z; Yan X; Miao C; Liu L; Liu S; Xia Y; Fang W; Zheng D; Luo Q
Cancer Cell Int; 2023 Sep; 23(1):220. PubMed ID: 37770914
[TBL] [Abstract][Full Text] [Related]
15. Erratum to: Triptolide inhibits thegrowth of osteosarcoma by regulating microRNA-181a via targeting PTEN gene in vivo and vitro.
Jiang C; Fang X; Zhang H; Wang X; Li M; Jiang W; Tian F; Zhu L; Bian Z
Tumour Biol; 2024; 45(1):147-148. PubMed ID: 38552127
[No Abstract] [Full Text] [Related]
16. Serum HOTAIR and GAS5 levels as predictors of survival in patients with glioblastoma.
Shen J; Hodges TR; Song R; Gong Y; Calin GA; Heimberger AB; Zhao H
Mol Carcinog; 2018 Jan; 57(1):137-141. PubMed ID: 28926136
[TBL] [Abstract][Full Text] [Related]
17. Modulation of CASC2/miR-21/PTEN pathway sensitizes cervical cancer to cisplatin.
Feng Y; Zou W; Hu C; Li G; Zhou S; He Y; Ma F; Deng C; Sun L
Arch Biochem Biophys; 2017 Jun; 623-624():20-30. PubMed ID: 28495512
[TBL] [Abstract][Full Text] [Related]
18. Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway.
Li Y; Ye Y; Feng B; Qi Y
J Cell Biochem; 2017 Dec; 118(12):4498-4507. PubMed ID: 28464252
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression.
Chang S; Chen B; Wang X; Wu K; Sun Y
BMC Cancer; 2017 Apr; 17(1):248. PubMed ID: 28388883
[TBL] [Abstract][Full Text] [Related]
20. Silence of cancer susceptibility candidate 9 inhibits gastric cancer and reverses chemoresistance.
Shang C; Sun L; Zhang J; Zhao B; Chen X; Xu H; Huang B
Oncotarget; 2017 Feb; 8(9):15393-15398. PubMed ID: 28146436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
